While Express Scripts (NASDAQ: ESRX ) , the largest pharmacy benefit manager in the country, has a firm grip on its industry, investors have been more concerned with getting a grip on the company's prospects for the future, especially after a negative outlook sent shares south late last year. In the following video, Motley Fool health care bureau chief quickly runs through his assessment of Express Scripts' guidance and discusses a few tailwinds and headwinds facing the company in the near future.
Do lower costs mean profits for your portfolio?
In 2011, a massive shift began. With the first of the baby-boomer generation reaching Medicare age, America's health care landscape was forever changed. Combine the aging population with the impact of Obamacare, and the need for innovative solutions for skyrocketing health care costs is as clear as ever. Express Scripts is part of that solution, and in this brand new premium report on the company, we clearly lay out the opportunity in front of this misunderstood stock. Claim your copy, and a year of free analyst updates, by clicking here now.